Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus
Mesenchymal stem cells (MSCs) are adult stem cells (ASCs) known for repairing damaged cells, exerting anti-inflammatory responses and producing immunoregulatory effects that can be significantly induced into insulin-producing cells (IPCs), providing an inexhaustible supply of functional β cells for...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2021/9938658 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832552781005717504 |
|---|---|
| author | Qiulan Huang Yanting Huang Jianping Liu |
| author_facet | Qiulan Huang Yanting Huang Jianping Liu |
| author_sort | Qiulan Huang |
| collection | DOAJ |
| description | Mesenchymal stem cells (MSCs) are adult stem cells (ASCs) known for repairing damaged cells, exerting anti-inflammatory responses and producing immunoregulatory effects that can be significantly induced into insulin-producing cells (IPCs), providing an inexhaustible supply of functional β cells for cell replacement therapy and disease modeling for diabetes. MSC therapy may be the most promising strategy for diabetes mellitus because of these significant merits. In this paper, we focused on MSC therapy for diabetes. |
| format | Article |
| id | doaj-art-6e7b4dbe3ee340b693352afcc192b088 |
| institution | Kabale University |
| issn | 1687-8337 1687-8345 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Endocrinology |
| spelling | doaj-art-6e7b4dbe3ee340b693352afcc192b0882025-02-03T05:57:51ZengWileyInternational Journal of Endocrinology1687-83371687-83452021-01-01202110.1155/2021/99386589938658Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes MellitusQiulan Huang0Yanting Huang1Jianping Liu2Department of Endocrinology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Endocrinology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Endocrinology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaMesenchymal stem cells (MSCs) are adult stem cells (ASCs) known for repairing damaged cells, exerting anti-inflammatory responses and producing immunoregulatory effects that can be significantly induced into insulin-producing cells (IPCs), providing an inexhaustible supply of functional β cells for cell replacement therapy and disease modeling for diabetes. MSC therapy may be the most promising strategy for diabetes mellitus because of these significant merits. In this paper, we focused on MSC therapy for diabetes.http://dx.doi.org/10.1155/2021/9938658 |
| spellingShingle | Qiulan Huang Yanting Huang Jianping Liu Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus International Journal of Endocrinology |
| title | Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus |
| title_full | Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus |
| title_fullStr | Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus |
| title_full_unstemmed | Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus |
| title_short | Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus |
| title_sort | mesenchymal stem cells an excellent candidate for the treatment of diabetes mellitus |
| url | http://dx.doi.org/10.1155/2021/9938658 |
| work_keys_str_mv | AT qiulanhuang mesenchymalstemcellsanexcellentcandidateforthetreatmentofdiabetesmellitus AT yantinghuang mesenchymalstemcellsanexcellentcandidateforthetreatmentofdiabetesmellitus AT jianpingliu mesenchymalstemcellsanexcellentcandidateforthetreatmentofdiabetesmellitus |